You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海王生物(000078.SZ):子公司“諾氟沙星膠囊”通過一致性評價
格隆匯 01-11 16:45

格隆匯1月11日丨海王生物(000078.SZ)公佈,公司收到公司控股子公司福州海王福藥製藥有限公司(以下簡稱“海王福藥”)通知獲悉,海王福藥近日收到了國家藥品監督管理局關於“諾氟沙星膠囊”的《藥品補充申請批准通知書》,該藥品通過仿製藥質量和療效一致性評價。

“諾氟沙星膠囊”為抗感染類處方藥,適用於敏感菌所致的尿路感染、淋病、前列腺炎、腸道感染和傷寒及其他沙門菌感染,為《國家基本藥物目錄(2018年版)》的品種之一,是海王福藥常年主要生產產品。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account